ARIDIS_LOGO.png
Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-K
April 26, 2023 12:15 ET | Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, announced today that it received a notice...
ARIDIS_LOGO.png
Aridis Provides Corporate Update
March 31, 2023 19:00 ET | Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., March 31, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on...
ARIDIS_LOGO.png
Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)
January 25, 2023 16:05 ET | Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced top-line results from the AR-301-002 Phase 3 study, which evaluated the superiority of...
HAP President and CE
HAP President and CEO Andy Carter to Retire Harrisburg, PA, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Andy Carter, president and CEO of The Hospital and Healthsystem Association of Pennsylvania (HAP) since 2012, today announced his plan to retire by...
Pa. Hospitals Recogn
Pa. Hospitals Recognized for Innovative COVID Response Harrisburg, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- The Hospital and Healthsystem Association of Pennsylvania (HAP) is recognizing four Pennsylvania health care teams for their exemplary projects...
HAP Announces 2020 A
HAP Announces 2020 Achievement Awards Winners Harrisburg, PA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- Pennsylvania is home to a diverse hospital community, whose leadership and staff are focused on weaving the needs of their patients into every facet...